Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dexamethasone phosphate
Drug ID BADD_D00624
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D07802
MeSH ID C004180
PubChem ID 9400
TTD Drug ID D0NA8U
NDC Product Code Not Available
UNII 2BP70L44PR
Synonyms dexamethasone 21-phosphate | dexamethasone phosphate | dexamethasone 21-phosphate, monosodium salt, (11beta,16alpha)-isomer | dexamethasone sodium phosphate | dexamethasonedisodium phosphate | dexamethasone phosphate disodium salt | Solu- Decadron | Spersadex | Spersadox | dexamethasone 21-phosphate, (6alpha,11beta,16alpha)-isomer | dexamethasone 21-phosphate, disodium salt, (11beta,16alpha)-isomer | dexamethasone 21-phosphate, disodium salt, (6alpha,11beta,16alpha)-isomer | Decadron phosphate | dexamethasone 21-phosphate, sodium salt, (11beta,16alpha)-isomer | dexamethasone 21-phosphate, copper (+2) salt (2:3), (11beta,16alpha)-isomer
Chemical Information
Molecular Formula C22H30FO8P
CAS Registry Number 312-93-6
SMILES CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)(O)O)O)C)O)F)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Osteoarthritis15.01.04.001--Not Available
Osteonecrosis24.04.05.004; 15.02.04.007--
Osteoporosis15.02.03.002; 14.04.04.002--
Pain08.01.08.004--
Pancreatitis07.18.01.001--
Pancreatitis acute07.18.01.002--Not Available
Papilloedema06.09.02.002; 24.03.07.001; 17.07.02.004--
Paraesthesia23.03.03.094; 17.02.06.005--
Pathological fracture16.32.03.007; 15.08.02.008; 12.04.02.006--Not Available
Peptic ulcer07.04.07.001--Not Available
Petechiae24.07.06.004; 23.06.01.003; 01.01.03.002--Not Available
Retinopathy of prematurity12.02.02.015; 06.10.02.012; 18.04.01.004--Not Available
Schizophrenia19.03.04.001--Not Available
Secondary adrenocortical insufficiency05.03.04.012; 14.11.01.014--Not Available
Seizure17.12.03.001--
Skin atrophy23.01.05.001--
Skin exfoliation23.03.07.003--Not Available
Skin hyperpigmentation23.05.01.003--
Skin striae23.01.05.002--Not Available
Small intestinal perforation07.04.06.006--
Sodium retention14.05.04.003--Not Available
Spinal compression fracture15.08.05.004; 14.04.04.003; 12.04.04.001--Not Available
Steroid withdrawal syndrome19.04.02.014; 08.06.02.013; 05.01.02.007--Not Available
Suicidal ideation19.12.01.003--
Telangiectasia24.03.03.003; 23.06.03.001--
Tendon rupture15.07.01.008; 12.01.07.003--Not Available
Tuberculosis11.04.01.006--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vasculitis10.02.02.006; 24.12.04.027--
Vertigo17.02.12.002; 04.04.01.003--
The 4th Page    First    Pre   4 5    Next   Last    Total 5 Pages